UBS ETF In order to proceed, you must confirm that you are a private investor based in Luxemburg.

  • Investments in these products should be made only after studying the current prospectus and Key Investor Information Document in detail.
  • The information was prepared without reference to any specific or future investment objective, financial or tax situation or requirement on the part of a particular individual or group.
  • The information is intended for information purposes only and constitutes neither an offer nor a solicitation to buy or sell securities of any kind or related financial instruments.
  • The products or securities described below may be unsuitable or prohibited for sale in all jurisdictions or to certain categories of investors.
  • The following information and opinions have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but are not guaranteed as being accurate, nor are they a complete statement or summary of the securities, markets or developments referred to.
  • The following details and opinions are provided without any guarantee or warranty and are for the recipient's personal use and information purposes only.
  • UBS AG and/or other members of the UBS Group may have a position in and may make purchases and/or sales of any of the securities or other financial instruments mentioned below.
  • This and the following information may not be reproduced, redistributed or republished for any purpose without written permission from UBS AG.
  • Representative in Luxembourg for UBS Funds established under foreign law: UBS Fund Services (Luxembourg) S.A. . Sales prospectuses, , Key Investor Information Documents, articles of association and contractual terms as well as annual and semi-annual reports of UBS Funds are available free of charge from  UBS ETF Sicav, 49, Avenue J.F. Kennedy, L-1855, Kirchberg, Luxembourg.
  • Units of the UBS Funds mentioned above may not be offered, sold or delivered in the US. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments.
  • The following information and charts may contain information on performance. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance.
  • If the currency of a financial product or financial service is different from your reference currency, the return may rise or fall as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient.
  • The details and opinions contained on this website are provided without any guarantee or warranty and are for the recipient’s personal use and information purposes only.
  • This and the following information does not constitute tax, legal or investment advice. Please contact your tax, legal and/or investment advisor.
  • The following information contain statements that constitute “forward-looking statements”, including, but not limited to, statements relating to our future business development. While these forward-looking statements represent our judgments and future expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations.
  • Source for all data and charts (if not indicated otherwise): UBS Asset Management. © UBS 2019
Back

UBS ETF (LU) MSCI EMU Value UCITS ETF (EUR) A-dis

Net asset value 34.1072 EUR

Last update

21.08.2019

ISIN: LU0446734369

Asset Class:  Equities

Securities lending

Securities lending is the temporary transfer of securities from the lender (the fund management company) in the name of and for the account of the investment fund to a third party (the borrower). In exchange, the borrower provides the lender with collateral before the delivery of securities, and pays a fee over the period of the loan. All loans within our lending programme are open and rolled daily such that they can be extended or terminated on demand. The fund can thus generate additional income. UBS ETFs engage in securities lending for selected, physically replicated UBS ETFs with the aim of reducing the investor’s net costs. Securities lending with UBS ETFs is always over-collateralised with at least 105% margin across all asset classes. In addition, on-loan balances are capped at 50% of each sub-fund’s AUM. Collateral is held in a custody account that is kept separate from the intermediary’s balance sheet. Daily revaluation at market prices ensures that the value of the collateral provided is always adjusted correctly. To further minimise risks, borrowers are carefully selected. The following types of securities are accepted as collateral (excl. securities of the borrowing counterparty):

  1. Securities issued and/or guaranteed by the governments of the following countries:
    • The following G10 countries: Belgium, the Netherlands, Canada, Sweden, France, Switzerland (SNB Bills), Germany, Japan, UK and USA (including US debt securities and rights issued or guaranteed by the US administration or one of its agencies or instrumentalities.)
    • Only the following OECD countries: Australia, Austria, Denmark, Finland, Luxembourg, New Zealand and Norway.
  2. Equities in the form of world stock indices.

Collateralisation of the securities lending is continually reviewed and adjusted as necessary. It can therefore be subject to change. For more details about Securities Lending Borrowers please follow the link.

Collateral 12 month lending summary (as of last month end)

Min % balance on loan:

4.23

Max % balance on loan:1)

11.74

Average % balance on loan:2)

7.13

Net return to fund in bps:3)

4.15

Collateral %:

105.86

Source: State Street

1) The maximum loan value is calculated from the maximum value of the lent securities on a single day within the past 12 months.

2) The average loan value is calculated by dividing the average percentage value of the securities lent on a daily basis by the fund's daily assets under management (AuM) over the past 12 months.

3) The fund's annualised net return generated by securities lending is calculated by dividing the fund's securities lending income over a period of 12 months by the fund's average net asset value (NAV) for the same period.

Of the revenue received by the borrower on the market, 60% is credited to the relevant sub-fund while UBS and lending agent receive 40% to cover the due diligence and operational costs resulting from the transactions carried out in relation to the securities lending.

Download all data as XLS File

Top 10 collateral holdings

#

Security

ISIN

Country

Asset Type

Weight %

1

CANADA, GOVERNMENT 4.000%/CPI IDX LINKED 99-01.12.31

CA135087WV25

Canada

Bonds

0.08

2

UNITED KINGDOM OF GREAT BRITAIN & N IRL 4.25000% 03-07.03.36

GB0032452392

United Kingdom

Bonds

0.07

3

AUSTRIA, REPUBLIC OF-144A-REG-S 0.75000% 16-20.10.26

AT0000A1K9C8

Austria

Bonds

0.04

4

FINLAND, REPUBLIC OF-144A-REG-S 1.37500% 17-15.04.47

FI4000242870

Finland

Bonds

0.03

5

UNITED KINGDOM OF GB & NI 0.500%/RPI LINKED 09-22.03.50

GB00B421JZ66

United Kingdom

Bonds

0.03

6

AMERICA, UNITED STATES OF 1.37500% 16-30.04.21

US912828Q780

United States

Bonds

0.02

7

AUSTRIA, REPUBLIC OF-REG-S 1.20000% 15-20.10.25

AT0000A1FAP5

Austria

Bonds

0.02

8

AMERICA, UNITED STATES OF 1.125%/CPI LINKED 11-15.01.21

US912828PP91

United States

Bonds

0.02

9

BELGIUM, KINGDOM OF-144A-REG-S 1.60000% 16-22.06.47

BE0000338476

Belgium

Bonds

0.02

10

AMERICA, UNITED STATES OF 1.75000% 15-28.02.22

US912828J439

United States

Bonds

0.02

The table above lists the securities that are used as collateral for the securities lent with UBS ETFs. The information presented was obtained from internal and external sources deemed reliable. However, we cannot provide any guarantee of their accuracy and completeness. It should be noted that securities lending is subject to a certain risk where the borrower does not return the borrowed securities according to his/her obligation, and where the value of the collateral provided does not cover the costs of repurchase of the securities. In this case, the borrower shall be liable for any claims arising from the securities lending and not covered by the sale of the securities concerned. Source: State Street, 20.08.2019

Collateral types and margins

Collateral Types

Loan Types

International Equities

Government Bonds

International Equities

105.00 %

105.00 %

US Equities

105.00 %

105.00 %

As per CISA regulation, the value of the collateral must at all times be equal to at least 100% of the market value of the securities lent; as such the requirements applicable to the UBS funds significantly exceed this requirement at all times. Source: State Street, 20.08.2019

Disclaimer

For marketing and information purposes by UBS. UBS funds under Luxembourg law. Before investing in this product please read the latest prospectus carefully and thoroughly. Prospectuses, simplified prospectuses or Key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS ETF Sicav, 49, Avenue J.F. Kennedy, L-1855, Kirchberg, Luxembourg or from UBS AG, P.O. Box , CH-4002 Basel, Switzerland. The MSCI indexes are the exclusive property of MSCI INC. (“MSCI”). MSCI and the MSCI index names are service mark(s) of MSCI or its affiliates and have been licensed for use for certain purposes by UBS AG (“UBS”). The financial securities referred to herein are not sponsored, endorsed, or promoted by MSCI, and MSCI bears no liability with respect to any such financial securities. The full prospectus of the UBS ETF Sicav contains a more detailed description of the limited relationship MSCI has with UBS and any related financial securities. No purchaser, seller or holder of this product, or any other person or entity, should use or refer to any MSCI trade name, trademark or service mark to sponsor, endorse, market or promote this product without first contacting MSCI to determine whether MSCI’s permission is required. Under no circumstances may any person or entity claim any affiliation with MSCI without the prior written permission of MSCI. Before investing in a product please read the latest prospectus carefully and thoroughly. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. Members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS Asset Management Switzerland AG or a local affiliated company. Source for all data and charts (if not indicated otherwise): UBS Asset Management. More explanations of financial terms can be found at ubs.com/glossary © UBS 2019. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.